Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Glycom Manufacturing A/S
A/S
Active
CVR 37207713
Limfjordsvej 4, 6715
Esbjerg N
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2015 · 10 years old
112 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Glycom Manufacturing A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KR
Kjeld Raunkjær Kjeldsen
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
JM
Jesper Mørk
Chief Executive Officer
Chief Executive Officer
2015 – 2022
HG
Hervé Geoffrey Hartmann
Chief Executive Officer
Chief Executive Officer
2022 – 2025
BK
Bent Kemplar
Management
Management
2015 – 2015
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MW
Michel Wilhelm Léon Meertens
Board of Directors
Board of Directors
2025
GS
Gernot Stadlmann
Board of Directors
Board of Directors
2025
Former (11)
OE
Odd Erik Hansen
Chairman
Chairman
2019 – 2021
JB
John Brett Theroux
Chairman
Chairman
2015 – 2019
JM
Joseph Maria Antonius Arets
Chairman
Chairman
2021 – 2022
LR
Luca Rosetto
Board of Directors
Board of Directors
2020 – 2021
CG
Carsten Gram Andersen
Board of Directors
Board of Directors
2019 – 2020
NA
Niels Axel Stokholm Banke
Board of Directors
Board of Directors
2015 – 2020
CB
Christina Bruun Geertsen
Board of Directors
Board of Directors
2015 – 2015
RD
Robert David Ellis
Chairman
Chairman
2022 – 2025
TT
Thomas Troelsgaard Kabel
Board of Directors
Board of Directors
2016 – 2019
JB
Jeppe Buskov
Chairman
Chairman
2015 – 2015
AG
Anders Glargaard
Board of Directors
Board of Directors
2021 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
GLYCOM A/S
Company
100%
100%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Glycom Manufacturing A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network